Biological Material Transfer Agreement Template for Indonesia

When you're involved in transferring biological materials in Indonesia, you need a Biological Material Transfer Agreement (MTA) to ensure legal compliance and protect all parties' interests. This specialized contract governs the exchange of genetic resources, biological specimens, cells, proteins, and other biological materials between research institutions, universities, biotech companies, and other organizations. Given Indonesia's status as a megadiverse country with strict biodiversity protection laws, having a properly structured MTA is not just recommended—it's legally required for most biological material transfers.

When do you need this document?

You'll need an MTA whenever you're transferring biological materials across organizational boundaries in Indonesia. This includes situations where universities share research specimens with pharmaceutical companies, when international researchers request access to Indonesian genetic resources, or when biotech firms collaborate on product development using biological materials. The agreement is particularly crucial for transfers involving endemic Indonesian species, traditional knowledge-related materials, or any biological resources that could lead to commercial applications. Even non-commercial academic exchanges typically require an MTA to establish clear usage terms and protect against unauthorized commercialization.

Key legal considerations

Your MTA must address several critical legal aspects to ensure enforceability and compliance. The agreement should clearly define the biological material being transferred, including its origin and any associated traditional knowledge. You need to specify permitted uses, whether for research only or including commercial applications, and establish intellectual property rights for any discoveries or innovations arising from the material. Benefit-sharing provisions are essential, particularly for genetic resources covered by the Nagoya Protocol, ensuring that Indonesia and local communities receive fair compensation for valuable biological resources. The agreement should also include confidentiality clauses, publication restrictions if applicable, and clear termination conditions. Additionally, you must address liability issues, insurance requirements, and dispute resolution mechanisms to protect all parties involved.

Legal requirements in Indonesia

Indonesian law imposes specific requirements on biological material transfers that your MTA must incorporate. Under Law No. 5 of 1990 on Conservation of Living Resources, you must obtain proper permits before transferring protected biological materials, and your agreement must demonstrate compliance with conservation objectives. The Nagoya Protocol implementation through Law No. 11 of 2013 requires that your MTA includes access and benefit-sharing (ABS) provisions, particularly for genetic resources and associated traditional knowledge. Foreign institutions must comply with Government Regulation No. 41 of 2006, which mandates research licenses for international collaborations. Your agreement must also align with Law No. 18 of 2002 on the National System of Research and Development, ensuring that material transfers support Indonesia's scientific advancement. Finally, any potential patent applications arising from transferred materials must comply with Law No. 13 of 2016 on Patents, which recognizes Indonesia's sovereignty over its genetic resources.